Funding for this research was provided by:
Astellas Pharma Inc
Received: 2 February 2017
Accepted: 5 April 2018
First Online: 19 April 2018
Ethics approval and consent to participate
: All patients provided Institutional Review Board (IRB)-approved written informed consent prior to any study-related procedures. The IRB approved the protocol, informed consent and patient information.
: CS, KG and TW are employees of Astellas Pharma Inc.SH has received grants, speaker and consultancy fees from Astellas, Allergan, and Ipsen, and speaker and consultancy fees from Merus and Pfizer.DS has received grants, speaker and consultancy fees from Astellas, speaker and consultancy fees from Allergan, Velicept, StimGuard, NewUro, and Inpellis, and has patents related to surgical devices for stress incontinence with royalties paid.LMT has received speaker and consultancy fees from Astellas and Pfizer.JF has received investigator fees from Astellas, and is managing director/board chairman of Rational Surgical Solutions and has received sponsorship fees from Dendreon for Rational Surgical Solutions software application.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.